General Information of the Compound
Compound ID
CP0503275
Compound Name
8-Methyl-4-morpholin-4-yl-chromen-2-one
    Show/Hide
Synonyms
8-Methyl-4-morpholin-4-yl-chromen-2-one
8-methyl-4-morpholin-4-yl-chromen-2-one
CHEMBL369452
    Show/Hide
Structure
Formula
C14H15NO3
Molecular Weight
245.278
Canonical SMILES
Cc1cccc2c(cc(=O)oc12)N1CCOCC1
    Show/Hide
InChI
InChI=1S/C14H15NO3/c1-10-3-2-4-11-12(9-13(16)18-14(10)11)15-5-7-17-8-6-15/h2-4,9H,5-8H2,1H3
    Show/Hide
InChIKey
HXUJEFDGGXBUQX-UHFFFAOYSA-N
Physicochemical Property
logP
1.93802
Rotatable Bonds
1
Heavy Atom Count
18
Polar Areas
42.68
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Complexity
18

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10857738
SID: 15901205
ChEMBL ID
CHEMBL369452
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00955, DNA-dependent protein kinase catalytic subunit
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
IC50 = 8050 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 8-Methyl-4-morpholin-4-yl-chromen-2-one )
Drug Name 8-Methyl-4-morpholin-4-yl-chromen-2-one
Target(s)
DNA-dependent protein kinase catalytic (PRKDC)
Inhibitor